ACL

AUCLINICAL FPO [ACL]
Australian Clinical Labs Limited provides pathology diagnostic services in Australia. The company offers range of services, including molecular cancer, harmony NIPT, genetic carrier screening and other antenatal, cardiac, and commercial drug and alcohol testing services; chemical pathology, haematology, histopathology and cytopathology, serology and microbiology, allergy and immunology, and veterinary and functional pathology services; pathology services for clinical trials; and CPD programs. It serves doctors, patients, and corporate clients. The company was incorporated in 2020 and is headquartered in Clayton, Australia.
Healthcare · ASX Small Cap
$2.3300 -1.3%

Updated 21 Jul 2026 · Signals refresh every scan

Get alerts when ACL triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track ACL — Free

Active Signals

Bullish Signals

  • Trading above both moving averages — the trend is your friend here
  • Watch out — volume is flowing out even as price holds up. Distribution pattern
  • Beating the Small Ords index — relative strength of 1.17, so it's outpacing the pack
  • Cash positive / operating cashflow positive
  • Low P/S ratio (0.6x)
  • EPS estimates revised upward (+10pts)
  • New substantial holder(s) (1)
  • Substantial holder(s) ceased (1)
  • Elevated short interest (6.6%)
  • Earnings in sharp decline (-52% QoQ)
  • CANSLIM I: Institutional ownership (95%)
  • Sentiment is mixed — no strong consensus either way
  • Altman Z-Score grey zone (2.32, low-confidence approx)
  • Days to cover very high (21.3)
  • RBA hiking (-3pts)

Risk Signals

  • Below the 200-day average — the long-term trend is still working against it
  • Post-earnings drift: negative surprise (SUE -10)
  • Not enough chatter to gauge sentiment — defaulting to neutral
Ask Scout AI about ACL
"What's driving ACL today?" "How does ACL compare to peers?" "Key risks for ACL?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Notification regarding unquoted securities - ACL
NONE Change in substantial holding from MUFG
NONE Change in substantial holding
HIGH Ceasing to be a substantial holder
HIGH Becoming a substantial holder
Announcement tone +3pts

Recent ASX Announcements

2026-07-20 Notification regarding unquoted securities - ACL
2026-07-17 Change in substantial holding from MUFG
2026-07-16 Change in substantial holding
2026-07-13 Ceasing to be a substantial holder
2026-07-09 Becoming a substantial holder

Key Metrics

$434.6M
Market Cap
580K
Avg Volume
1.2x
Vol Ratio
$1.83 — $2.97
52-Week Range
6.6%
Short Interest
N/A
Cash Runway
16.7%
ROE
3.6%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: -52%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 93%
LLeader vs LaggardpassRS: 6
IInstitutional SponsorshippassInst: 95%
MMarket DirectionneutralNeutral

Sector: Healthcare

111 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
ECS +20.0%VHL -15.4%NTI +12.5%PIQ -11.4%OSL -10.3%
Compare:ACL vs ECSACL vs VHLACL vs NTI
Scout Pro — Deeper Analysis for ACL
Try Pro free for 30 days
Share this analysis

Track ACL and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required